Titre : |
Enhancing nocturnal processes for beautiful skin |
Type de document : |
texte imprimé |
Auteurs : |
Justine Cotton, Auteur ; Catherine Gondran, Auteur ; Elodie Oger, Auteur ; Karine Cucumel, Auteur |
Année de publication : |
2020 |
Article en page(s) : |
p. 67-70 |
Note générale : |
Bibliogr. |
Langues : |
Anglais (eng) |
Catégories : |
Cosmétiques Eco-conception Huile essentielle de lavande Peau -- Soins et hygiène Principe actif biofonctionnel Régénération (biologie)
|
Index. décimale : |
668.5 Parfums et cosmétiques |
Résumé : |
Ashland has unlocked the secret of our skin at night so you can awaken like Sleeping Beauty from your slumber, with skin re-set for the day ahead. Ashland Nightessenceâ„¢ biofunctional was developed to enhance the naturally occurring nocturnal process that helps skin boost molecules such as timezyme and melatonin.
Leveraging off the current beauty sleep trend, this is the first biofunctional of its kind tailored to understand and optimise skin’s nighttime needs. It helps restore it overnight, so skin looks rested, renewed and illuminated by morning.
Nightessence was eco-consciously designed from field-to-skin. Our premium lavender is grown sustainably on the mountain slopes in Provence, France, and the flowers are extracted using Ashland’s proprietary Plant Small RNA technology to offer a novel type of lavender essence to the cosmetic market. |
Note de contenu : |
- The 'blue gold' of Provence Alps, on the road of summer
- A novel premium lavender essence for the cosmetic market
- An eco-design from field-to-skin
- Introducing the biology of nighttime skin
- An answer to the growing beauty sleep trend
- Fig. 1 : Farytale lavender landscapes in Valensole at 700 metre in July
- Fig. 2 : Plant small RNA technology
- Fig. 3 : Skin's noctology refers to essential nocturnal processes for a skin renewed by the morning
- Fig. 4 : Melatonin immunostaining on skin biopsy with application of Nightessence or a benchmark at 0.5 %
- Fig. 5 : Timezyme immunostaining on skin biopsy with application of Nightessence or a benchmark at 0.5 %
- Fig. 6 : ROS detection on keratinocytes exposed to artificial daylight and treated with Nightessence or a benchmark at 0.1 %
- Fig. 7 : Detection of dark CPDs on melanocytes 16 hours after UVB exposure and treated with Nightessence or a benchmark at 0.1 %
- Fig. 8 : Dark circle improvement results |
En ligne : |
https://drive.google.com/file/d/1ND2sT_Fl4OJjaggSeiHFgqTVfxHvnKsS/view?usp=drive [...] |
Format de la ressource électronique : |
Pdf |
Permalink : |
https://e-campus.itech.fr/pmb/opac_css/index.php?lvl=notice_display&id=33953 |
in PERSONAL CARE EUROPE > Vol. 14, N° 2 (04/2020) . - p. 67-70